Clearance Summary
EnCor EnCompass Breast Biopsy and Tissue Removal System received FDA 510(k) clearance under submission number K262571, sponsored by Bard Peripheral Vascular, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the Gastroenterology, Urology review panel. The statutory decision date of record is 2026-08-14.
- Submission: K262571
- Applicant / Sponsor: Bard Peripheral Vascular, Inc.
- Clearance pathway: Special
- Review panel: Gastroenterology, Urology
- Device class: Class II
- Regulation citation: 21 CFR 876.1075
- Decision date: 2026-08-14
Classification & Regulation
This clearance is catalogued under FDA product code KNW and 21 CFR 876.1075, within the Gastroenterology, Urology review panel as a Class II device.